Pharma "still the most profitable US industry"

5 December 2001

A new report from the US Kaiser Family Foundation says that, compared toother industries, the drug sector continues to earn the highest profit rates. Profits as a percentage of revenues for the industry were over four times the median rate for all Fortune 500 firms in the late 1990s, at 18.6% of revenues for drug firms against 4.5% for all Fortune 500 firms in 2000, it found.

The finding was part of a larger study that showed the drug sector spends more than any other US industry on consumer advertising (see page 14). Since 1996, spending on drug advertising has more than tripled, said Larry Levitt, who helped direct the study. In 2000, drug firms spent $15.7 billion, or 14% of their revenues, on promotions, compared with 3.7% of revenues spent by department stores, 3.9% for tobacco products, 10.7% for soap and detergents and 12% for games or toys.

While companies blame the high costs of their drugs on R&D expenses, in fact they spend only 14% of revenues in this area, says the study, adding that profits exceeded R&D, at 24% compared to 14%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight